Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 464-471

  Malott, Rebecca J ^a   Steen Kinnaird, Barbara R ^a   Lee, Tracy D ^a   Speert, David P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; HOPANOID; LIPOPOLYSACCHARIDE; POLYMYXIN; POLYMYXIN B;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOSYNTHESIS; BURKHOLDERIA; BURKHOLDERIA MULTIVORANS; GENE CLUSTER; GENE LOCUS; GENETIC ANALYSIS; MEMBRANE PERMEABILITY; NEUTROPHIL; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; STRESS; TRANSPOSON;

1-NAPHTHYLAMINE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; COLISTIN; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; GENOMIC LIBRARY; MICROBIAL SENSITIVITY TESTS; MULTIGENE FAMILY; MUTATION; OPEN READING FRAMES; POLYMYXIN B; STEROLS;

EID: 84455170078     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00602-11     Document Type: Article

References (52)

1. Altas RM. 1993. Acid broth, p 52. In Parks LC (ed), Handbook of microbiological media. CRC Press, Inc, Boca Raton, FL.
2. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Ausubel F, et al. 1989. Current protocols in molecular biology. John Wiley & Sons, Inc, New York, NY.
4. Bumford AA, Spilker T, LiPuma J. 2010. Epidemiology of Burkholderia infection in U.S. CF patients. International Burkholderia cepacia Working Group, Seattle, WA.
5. Burtnick MN, Woods DE. 1999. Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob. Agents Chemother. 43:2648-2656. (Pubitemid 29519543)
6. Campos MA, et al. 2004. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72:7107-7114. (Pubitemid 39552380)
7. Cheng HP, Lessie TG. 1994. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J. Bacteriol. 176:4034-4042. (Pubitemid 24191288)
8. Corey M, Farewell V. 1996. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am. J. Epidemiol. 143:1007-1017. (Pubitemid 26140328)
9. Cox AD, Wilkinson SG. 1991. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol. Microbiol. 5:641-646. (Pubitemid 21896085)
10. Cvejic JH, et al. 2000. Bacterial triterpenoids of the hopane series as biomarkers for the chemotaxonomy of Burkholderia, Pseudomonas and Ralstonia spp. FEMS Microbiol. Lett. 183:295-299. (Pubitemid 30079664)
11. Drevinek P, Mahenthiralingam E. 2010. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin. Microbiol. Infect. 16:821-830.
12. Dubarry N, Du W, Lane D, Pasta F. 2010. Improved electrotransformation and decreased antibiotic resistance of the cystic fibrosis pathogen Burkholderia cenocepacia strain J2315. Appl. Environ. Microbiol. 76: 1095-1102.
13. Eberl M, et al. 2002. Accumulation of a potent gammadelta T-cell stimulator after deletion of the lytB gene in Escherichia coli. Immunology 106: 200-211. (Pubitemid 34621828)
14. Figurski DH, Helinski DR. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. U. S. A. 76:1648-1652. (Pubitemid 9175374)
15. Glukhov E, Stark M, Burrows LL, Deber CM. 2005. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J. Biol. Chem. 280:33960-33967. (Pubitemid 41443116)
16. Govan JR, Brown AR, Jones AM. 2007. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2:153-164. (Pubitemid 46766989)
17. Hancock RE, Raffle VJ, Nicas TI. 1981. Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 19:777-785. (Pubitemid 11092072)
18. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86. (Pubitemid 28269135)
19. Horbach S, Neuss B, Sahm H. 1991. Effect of azasqualene on hopanoid biosynthesis and ethanol tolerance of Zymomonas mobilis. FEMS Microbiol. Lett. 79:347-350.
20. Isles A, et al. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210. (Pubitemid 14188925)
21. Kannenberg EL, Poralla K. 1999. Hopanoid biosynthesis and function in bacteria. Naturwissenschaften 86:168-176. (Pubitemid 29200204)
22. Loh B, Grant C, Hancock RE. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551. (Pubitemid 14018094)
23. Loutet SA, Flannagan RS, Kooi C, Sokol PA, Valvano MA. 2006. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J. Bacteriol. 188:2073-2080. (Pubitemid 43376461)
24. Loutet SA, Mussen LE, Flannagan RS, Valvano MA. 2011. A two-tier model of polymyxin B resistance in Burkholderia cenocepacia. Environ. Microbiol. Rep. 3:278-285.
25. Loutet SA, Valvano MA. 2011. Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Front. Microbiol. 2:159.
26. Mahenthiralingam E, Urban TA, Goldberg JB. 2005. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 3:144-156. (Pubitemid 40207595)
27. Manniello JM, Heymann H, Adair FW. 1978. Resistance of spheroplasts and whole cells of Pseudomonas cepacia to polymyxin B. Antimicrob. Agents Chemother. 14:500-504. (Pubitemid 9025678)
28. Moore RA, Bates NC, Hancock RE. 1986. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29: 496-500. (Pubitemid 16143261)
29. Moore RA, Chan L, Hancock RE. 1984. Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:539-545. (Pubitemid 14018093)
30. Moore RA, Hancock RE. 1986. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob. Agents Chemother. 30:923-926. (Pubitemid 17209150)
31. Nicas TI, Hancock RE. 1983. Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. J. Gen. Microbiol. 129: 509-517. (Pubitemid 13186938)
32. Nzula S, Vandamme P, Govan JR. 2002. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 50:265-269. (Pubitemid 34918859)
33. Ortega X, et al. 2009. Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin B. J. Biol. Chem. 284:21738-21751.
34. Pearson A, Flood Page SR, Jorgenson TL, Fischer WW, Higgins MB. 2007. Novel hopanoid cyclases from the environment. Environ. Microbiol. 9:2175-2188. (Pubitemid 47222111)
35. Peeters E, Nelis HJ, Coenye T. 2009. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/ sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J. Antimicrob. Chemother. 64:801-809.
36. Perzl M, et al. 1998. Cloning of conserved genes from Zymomonas mobilis and Bradyrhizobium japonicum that function in the biosynthesis of hopanoid lipids. Biochim. Biophys. Acta 1393:108-118. (Pubitemid 28495595)
37. Rajyaguru JM, Muszynski MJ. 1997. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds. J. Antimicrob. Chemother. 40:345-351. (Pubitemid 27437952)
38. Rajyaguru JM, Muszynski MJ. 1998. Sensitization of Burkholderia cepacia to antibiotics by cationic drugs. J. Antimicrob. Chemother. 41:277-280. (Pubitemid 28083133)
39. Rezanka T, Siristova L, Melzoch K, Sigler K. 2010. Hopanoids in bacteria and cyanobacteria-their role in cellular biochemistry and physiology, analysis and occurrence. Mini Rev. Org. Chem. 7:300-313.
40. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Schmidt A, Bringer-Meyer S, Poralla K, Sahm H. 1986. Effect of alcohols and temperature on the hopanoid content of Zymomonas mobilis. Appl. Microbiol. Biotechnol. 25:32-36. (Pubitemid 17009184)
42. Schweizer HP. 1992. Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol. Microbiol. 6:1195-1204.
43. Speert DP, Bond M, Woodman RC, Curnutte JT. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. 170:1524-1531. (Pubitemid 24369913)
44. Stieritz DD, Holder IA. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131:688-691.
45. Vermis K, Vandamme PA, Nelis HJ. 2003. Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. J. Appl. Microbiol. 95:1191-1199. (Pubitemid 37506106)
46. Welander PV, et al. 2009. Hopanoids play a role in membrane integrity and pH homeostasis in Rhodopseudomonas palustris TIE-1. J. Bacteriol. 191:6145-6156.
47. West SE, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86.
48. Whiteford ML, et al. 1995. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50:1194-1198.
49. Woods D. 1984. Oligonucleotide screening of cDNA libraries. Focus 6:1-2.
50. Zahariadis G, Levy MH, Burns JL. 2003. Cepacia-like syndrome caused by Burkholderia multivorans. Can. J. Infect. Dis. 14:123-125. (Pubitemid 36682111)
51. Zavascki AP, Goldani LZ, Li J, Nation RL. 2007. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother. 60:1206-1215. (Pubitemid 350168315)
52. Zlosnik JE, Henry DA, Speert DP. 2011. Burkholderia cepacia complex infections in Vancouver and British Columbia from 1981 to 2010. International Burkholderia cepacia Working Group, Prague, Czech Republic.